61 – 70 of 110
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Distinct tau PET patterns in atrophy-defined subtypes of Alzheimer's disease
- Contribution to journal › Article
-
Mark
[18F]Flortaucipir distinguishes Alzheimer’s disease from progressive supranuclear palsy pathology in a mixed-pathology case
- Contribution to journal › Letter
-
Mark
Head-to-head comparison of tau positron emission tomography tracers [18F]flortaucipir and [18F]RO948
- Contribution to journal › Article
-
Mark
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
- Contribution to journal › Article
-
Mark
No symphony without bassoon and piccolo : Changes in synaptic active zone proteins in Huntington's disease
- Contribution to journal › Article
-
Mark
Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease from Other Neurodegenerative Disorders
- Contribution to journal › Article
-
Mark
The implications of different approaches to define AT(N) in Alzheimer disease
- Contribution to journal › Article
-
Mark
Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease
- Contribution to journal › Article
-
Mark
Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET
- Contribution to journal › Article
